Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Citalopharm and Fluvoxamine on Platelet Response to Clopidogrel, a Randomized, Double-blind, Crossover Trial

NCT01396720 is registered in ClinicalTrials.gov with Hadassah Medical Organization as lead sponsor.

NCT NCT01396720
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01396720 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Citalopharm and Fluvoxamine on Platelet Response to Clopidogrel, a Randomized, Double-blind, Crossover Trial
Lead sponsor
Hadassah Medical Organization
Phase
Phase 1
Overall status
Completed
Start date
September 30, 2011
Completion date
December 31, 2012
Enrollment
15 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

drug interactions between clopidogrel and serotonin reuptake inhibitors